GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (NAS:VTRS) » Definitions » Shiller PE Ratio
中文

Viatris (Viatris) Shiller PE Ratio

: 14.02 (As of Today)
View and export this data going back to 1986. Start your Free Trial

As of today (2024-04-24), Viatris's current share price is $11.36. Viatris's E10 for the quarter that ended in Dec. 2023 was $0.81. Viatris's Shiller PE Ratio for today is 14.02.

The historical rank and industry rank for Viatris's Shiller PE Ratio or its related term are showing as below:

VTRS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.87   Med: 26.31   Max: 173.66
Current: 14.01

During the past years, Viatris's highest Shiller PE Ratio was 173.66. The lowest was 8.87. And the median was 26.31.

VTRS's Shiller PE Ratio is ranked better than
78.99% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.405 vs VTRS: 14.01

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Viatris's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.640. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.81 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Viatris Shiller PE Ratio Historical Data

The historical data trend for Viatris's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.48 16.63 14.31 11.34 13.35

Viatris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.34 9.79 10.45 10.52 13.35

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris Shiller PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Viatris's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Viatris's Shiller PE Ratio falls into.



Viatris Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Viatris's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=11.36/0.81
=14.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Viatris's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.64/129.4194*129.4194
=-0.640

Current CPI (Dec. 2023) = 129.4194.

Viatris Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.290 99.695 0.376
201406 0.320 100.560 0.412
201409 1.260 100.428 1.624
201412 0.470 99.070 0.614
201503 0.130 99.621 0.169
201506 0.320 100.684 0.411
201509 0.830 100.392 1.070
201512 0.380 99.792 0.493
201603 0.030 100.470 0.039
201606 0.330 101.688 0.420
201609 -0.230 101.861 -0.292
201612 0.780 101.863 0.991
201703 0.120 102.862 0.151
201706 0.550 103.349 0.689
201709 0.160 104.136 0.199
201712 0.460 104.011 0.572
201803 0.170 105.290 0.209
201806 0.070 106.317 0.085
201809 0.340 106.507 0.413
201812 0.100 105.998 0.122
201903 -0.050 107.251 -0.060
201906 -0.330 108.070 -0.395
201909 0.370 108.329 0.442
201912 0.040 108.420 0.048
202003 0.040 108.902 0.048
202006 0.080 108.767 0.095
202009 0.360 109.815 0.424
202012 -1.590 109.897 -1.872
202103 -0.860 111.754 -0.996
202106 -0.230 114.631 -0.260
202109 0.260 115.734 0.291
202112 -0.220 117.630 -0.242
202203 0.330 121.301 0.352
202206 0.260 125.017 0.269
202209 0.290 125.227 0.300
202212 0.830 125.222 0.858
202303 0.190 127.348 0.193
202306 0.220 128.729 0.221
202309 0.270 129.860 0.269
202312 -0.640 129.419 -0.640

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Viatris  (NAS:VTRS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Viatris Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Viatris's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Viatris (Viatris) Business Description

Address
1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Executives
Andrew Cuneo officer: See Remarks 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Xiangyang (sean) Ni officer: President, Greater China 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Leo Frans Groothuis director 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Scott Andrew Smith director C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901
Elisha W Finney director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Van Der Meer Mohr Pauline director 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Menassie Taddese officer: See Remarks 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Robert J Coury director, officer: Executive Chairman BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL
W Don Cornwell director
Brian Roman officer: Global General Counsel 1000 MYLAN BOULEVARD, CANONSBURG PA 15317
Anthony Mauro officer: See Remarks BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL
James M Kilts director 120 PARK AVE, NEW YORK NY 10017
Melina E Higgins director BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Ian C Read director PFIZER INC ATTN CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Dillon Joellen Lyons director BUILDING 4, TRIDENT PLACE, MOSQUITO WAY, HATFIELD, HARTFORDSHIRE X0 AL 109UL